ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 376739 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 376739; 2) Community: the network communities that were significantly associated with the response to NSC 376739; 3) Molecule: the relationships between components within communities and NSC 376739; 4) MDR: the compounds that were significantly associated with the NSC 376739.

NSC Compound Enrichment Correlation
NSC 726444 4,11-bis[[2-(methylamino)ethyl]amino]-3-[(dimethylamino)meth yl]-1H-naphtho[2,3-f]indole-5,10-dione 0.0202245331784479 0.25262915
NSC 727985 NSC 708781 incorporated in micelles, 0.55% (w/w) of drug 0.0202245331784479 0.10667557
NSC 728319 6-(3-Homopiperazinyl1-1-propyl)-5,6-dihydro-2,3-dimethoxy-8, 9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline Dihydrochloride 0.0202245331784479 0.75730532
NSC 730460 16-[4-{(3-Imidazol-1-yl)propoxy}-3-methoxybenzylidene]-3b-py rrolidino-5-androsten-17b-YL acetate 0.0202245331784479 0.25816727
NSC 744231 Null 0.0202245331784479 0.49510102
NSC 745923 Null 0.0202245331784479 0.070504596
NSC 75140 Benzenesulfonamide, 4-[(6,7-dihydro-6-thioxo-1H-purin-8-yl)azo]- 0.0202245331784479 0.11882288
NSC 756471 SB-732941 0.0202245331784479 -0.043530014
NSC 77830 Cycloguanil Pamoate (USAN) 0.0202245331784479 0.26890899
NSC 117281 ANTINEOPLASTIC-117281 0.0220039422291536 0.31679245
Total:94  Current:43    [First] [Prev] [Next] [Last]